Cargando…

Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is a highly heterogeneous malignancy with an extremely high mortality rate. Necroptosis is a programmed cell death mode mediated by three major mediators, RIPK1, RIPK3, and MLKL, and has been shown to play a role in various cancers. To date, the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jiaqi, Wang, Jinjie, Wang, Tianyi, Zhou, Hao, Xu, Mingming, Zha, Jiliang, Feng, Chen, Shen, Zihao, Jiang, Yun, Chen, Jianle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367639/ https://www.ncbi.nlm.nih.gov/pubmed/35965497 http://dx.doi.org/10.3389/fonc.2022.955186

Ejemplares similares

Necroptosis-Related Genes Signatures Identified Molecular Subtypes and Underlying Mechanisms in Hepatocellular Carcinoma
por: Wei, Jianguo, et al.
Publicado: (2022)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma
por: Wang, Ye, et al.
Publicado: (2022)

Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer
por: Xu, Yuhao, et al.
Publicado: (2022)

Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer
por: Zhu, Jiaqi, et al.
Publicado: (2022)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas
por: Ba, Yueyang, et al.
Publicado: (2022)

Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer
por: Cao, Tiefeng, et al.
Publicado: (2022)

Identification of necroptosis subtypes and development of necroptosis-related risk score model for in ovarian cancer
por: Ji, Chen, et al.
Publicado: (2022)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
por: Zhang, Weiyu, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
por: Zhou, Zunjie, et al.
Publicado: (2022)

Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer
por: Sun, Mengyu, et al.
Publicado: (2022)

Identification of Subtype-Specific Metastasis-Related Genetic Signatures in Sarcoma
por: Li, Ya-Ling, et al.
Publicado: (2020)

Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma
por: Zhou, Qin, et al.
Publicado: (2022)

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
por: Song, Chong, et al.
Publicado: (2022)

A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma
por: Xia, Pengfei, et al.
Publicado: (2022)

Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
por: Wang, Zhifeng, et al.
Publicado: (2022)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer
por: Nie, Sipei, et al.
Publicado: (2023)

Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer
por: Zhang, Jili, et al.
Publicado: (2023)

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
por: Fan, Zongyao, et al.
Publicado: (2023)

Characterizing the prognostic and therapeutic value of necroptosis in sarcoma based on necroptosis subtypes
por: Ma, Yibo, et al.
Publicado: (2022)

Upregulation of miR-664a-3p Ameliorates Calcific Aortic Valve Disease by Inhibiting the BMP2 Signaling Pathway
por: Jiang, Yun, et al.
Publicado: (2022)

A necroptosis‐related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma
por: Chen, Junliang, et al.
Publicado: (2022)

Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes
por: Serrano-Carbajal, Erandi A., et al.
Publicado: (2020)

Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer
por: Bao, Bowen, et al.
Publicado: (2019)

Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
por: Shen, Chong, et al.
Publicado: (2022)

Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis
por: Cheng, Hong, et al.
Publicado: (2021)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Necroptosis-related lncRNAs: Combination of bulk and single-cell sequencing reveals immune landscape alteration and a novel prognosis stratification approach in lung adenocarcinoma
por: Yao, Yizhu, et al.
Publicado: (2022)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
por: Zhao, Zihan, et al.
Publicado: (2022)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes
por: Pan, Tao, et al.
Publicado: (2021)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pk2m5uakk645d17aevs6pb9ii3